Compare top Chemotherapy for breast cancer doctors and prices in Turkey. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
2
Turkey
Reviews
14,000+
From real patients
Compare prices for Chemotherapy for breast cancer across top countries
Tap a country to view top doctors and prices
Most popular range
$800
$1.2K
$1.6K
$2K
$2.4K
$2.8K
$3.2K
$3.6K
$1,400 – $2,300
Most patients pay within this range
The exact cost depends on the chosen doctor, technique, areas treated, and your individual needs.
Get a precise quote for your case.
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Dr. Mutlu specializes in chemotherapy and targeted therapies for breast cancer at Medical Park Antalya Hospital Complex.
Dr. Alemdar specializes in medical oncology with extensive training at Akdeniz University – one of Turkey's leading medical schools.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
278 patients from Turkey have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | 27 years of experience | Targeted breast cancer therapies | Specializes in chemotherapy and targeted therapies with expertise in next-generation genetic research. Associate professor at Akdeniz University. | Turkey | Price on request
| |
| #2 | 20 years of experience | Breast cancer chemotherapy | Specializes exclusively in medical oncology with board certification. Trained at Akdeniz University – Turkey's leading oncology center. | Turkey | Price on request
|
Turkey hosts top-rated medical oncologists who specialize in personalized breast cancer care at JCI-accredited centers. These specialists often hold European Society for Medical Oncology (ESMO) certification and international fellowships. They provide advanced systemic therapies like targeted treatment and immunotherapy alongside traditional chemotherapy protocols.
Bookimed Expert Insight: Data shows that leading Turkish oncologists like Prof. Necdet Uskent and Prof. Cemil Bilir have over 20 to 40 years of experience. Many have rotated through elite US institutions such as the Cleveland Clinic or MD Anderson. This international exposure allows them to implement the latest global oncology protocols for complex breast cancer cases.
Patient Consensus: Patients note that coordinated care between medical oncologists and surgeons at centers like Anadolu makes a big difference. They emphasize how important it is to have clear, written chemo schedules. Many felt more confident when doctors proactive managed side effects rather than just following a rigid plan.
Leading Turkish breast cancer oncologists hold advanced academic titles like Professor and Associate Professor. They possess mandatory Ministry of Health licenses and specialized medical oncology certifications. Many experts hold international credentials from the European Society for Medical Oncology and have completed fellowships at renowned cancer centers.
Bookimed Expert Insight: A prevailing trend among top Turkish oncologists is the combination of military medical training with international research. Dr. Bulent Karagoz and Dr. Seref Komurcu at Anadolu Medical Center both held leadership roles at the Gulhane Military Medical Academy. This background often correlates with a high volume of complex cases and a strong focus on tumor biology research.
Patient Consensus: Patients often mention feeling reassured by the academic titles of their doctors. Many were surprised by how many specialists have over 20 years of experience and international training. They note that doctors like Dr. Yesim Yildirim explain complex immunotherapy options in very simple terms.
Breast cancer doctors in Turkey strictly follow international chemotherapy protocols to provide standardized care. Leading clinics align their treatments with guidelines from ASCO, ESMO, and the NCCN. Specialists utilize modern HER2 testing and genetic analysis to tailor drug regimens for every patient.
Bookimed Expert Insight: Turkey serves as a hub for oncology expertise where doctors often hold memberships in both Turkish and European medical societies. Dr. Eda Tanrikulu ranked third nationally in specialty exams and participates in international clinical studies. This dual engagement ensures patients receive the latest systemic therapies currently used in Western Europe and the US.
Patient Consensus: Patients note that treatment feels very consistent with standards they recognize from home. They emphasize that care teams focus entirely on the results and often include professional translators. Many survivors felt reassured by the coordinated approach between oncomammologists, anesthesiologists, and plastic surgeons.
Turkish oncologists design customized chemotherapy plans by integrating international ESMO and NCCN guidelines with tumor biology. Specialists utilize molecular profiling and multidisciplinary tumor boards to select specific drug combinations. These protocols account for genetic markers, organ function, and patient performance status.
Bookimed Expert Insight: Coordination between internal research and clinical practice is common among top Turkish specialists. For example, Dr. Yesim Yildirim at Anadolu Medical Center has 80+ publications and uses international training from the UK and Israel to apply advanced immunotherapy alongside chemotherapy. This academic background allows doctors to adjust protocols in real-time if a tumor develops resistance.
Patient Consensus: Patients note that their treatment plans often change after the surgical team provides the final pathology report. Many felt relieved when doctors explained that markers like lymph-node status or genomic risk, rather than just stage, drove their specific drug choice. They also appreciate how teams coordinate 24/7 to manage side effects during active cycles.